Recombinant Human IRF9 Protein (Baculovirus)，Strep & His

Interferon regulatory factor 9 (IRF9) is a critical transcription factor involved in the immune response, particularly in mediating the effects of type I interferons (IFNs). Research on IRF9 has gained prominence due to its essential role in various biological processes, including the antiviral response, immune regulation, and oncogenesis. This protein forms a complex with other STAT proteins, particularly STAT1 and STAT2, to promote the transcription of interferon-stimulated genes (ISGs), which are pivotal in enhancing the host's defense against viral infections. The dysregulation of IRF9 has been implicated in various pathological conditions, such as autoimmune diseases and cancer, making it a promising target for therapeutic interventions. Recent studies have focused on the characterization and production of recombinant IRF9 protein to better understand its structure-function relationships and regulatory mechanisms. The availability of recombinant IRF9 can facilitate high-throughput assays and functional studies aimed at exploring its interactions with other signaling pathways, assessing its role in immune modulation, and evaluating its potential as a biomarker or target for drug development. Given the increasing need for effective antiviral therapies and the complex nature of immune responses, the exploration of IRF9 and its therapeutic implications continues to be an exciting area of research in molecular and cellular biology.